{"filings":[{"id":2132756,"accession_number":"0001437749-26-026570","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2026-08-07T20:00:25+00:00","items":["5.02","9.01"],"status":"ready","headline":"Gyrodyne COO Peter Pitsiokos to depart Oct 2; $100K severance, $620K savings expected","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["COO Peter Pitsiokos' employment terminates Oct 2, 2026; separation agreement signed Aug 3.","Severance: $100,000 lump sum (6 months' pay) plus base salary through termination date.","Company will have one full-time employee remaining to oversee liquidation after his departure.","Expected savings of ~$620,000 over remaining liquidation timeline, targeted completion by end of 2028.","Pitsiokos retains eligibility for retention bonus under plan if property sale conditions met."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105892,"accession_number":"0001437749-26-001119","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Gyrodyne amends Flowerfield sale agreement with $1.52M credit, extends covenant deadline to Feb 5, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Second Amendment provides $1,520,222 credit to B2K for on-site improvements on Lots 1 and 3 of Flowerfield.","Investigation period expired; B2K's right to terminate under Section 3.1(D) is null and void.","Parties must resolve third-party land use covenants by Feb 5, 2026; B2K may terminate if unresolved.","Sanitary flow chart revised, allocating all remaining sanitary flow to B2K except for Lots 1-3.","Company states impact on timeline and net asset value is premature to determine due to covenant uncertainty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":122153,"accession_number":"0001437749-25-033874","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Gyrodyne LLC announces shareholder voting results from 2025 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Richard B. Smith elected as director with 1,394,282 votes for and 29,759 withheld.","Non-binding advisory vote on executive compensation approved: 1,392,477 for, 31,202 against.","Ratification of Baker Tilly US as auditor for 2025 fiscal year: 1,438,045 for, 284 against.","Broker non-votes totaled 38,531 on director election and compensation proposals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":122152,"accession_number":"0001437749-25-033184","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Gyrodyne CEO provides operational update; Flowerfield parcel sale for $28.74M targeted end of 2027","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 49 undeveloped acres of Flowerfield to B2K Development for $28.74M; close expected end 2027 subject to litigation & approvals.","Proforma NAV per share fell to $14.83 at June 2025 from $15.98 at Dec 2023; total NAV rose to $32.6M due to rights offering.","First half 2025 costs exceeded operating receipts by ~$700k, up $125k from 2024; occupancy 85% vs 86%.","Cortlandt Manor property has MOD designation; exploring mixed-use with residential to improve marketability.","Article 78 litigation hearing date awaited; decision expected in 2027. Board reduced to 4, chairman fee capped at $65k."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":122151,"accession_number":"0001437749-25-031273","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Gyrodyne settles with Star Equity; board reduced to four, Star Equity withdraws nominations","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Star Equity withdraws June 4, 2025 board nominations; board size cut from five to four.","Richard Smith sole nominee at 2025 annual meeting; director fees frozen, chairman cap $65k.","Star Equity agrees to standstill until Dec 31, 2026 (or Dec 31, 2027 if certain directors renominated).","Separate pact with Leap Tide includes voting commitment and standstill until 2028 annual meeting.","Director Paul Lamb, 28-year board member, will not stand for re-election."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138877,"accession_number":"0001437749-25-024553","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2025-08-04T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Gyrodyne signs agreement to sell 49-acre parcel for up to $28.74M; NAV per share rises to $14.83","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Purchase price range $24M-$28.74M, estimated final price $28.74M; buyer B2K Smithtown LLC.","Estimated NAV as of June 30, 2025: $32.6M ($14.83/share), up 6% from Q1 NAV of $30.8M ($14.01).","Sale expected to close by Dec 2027 (or Aug 2028 with extensions); liquidation timeline extended to Dec 31, 2027.","Transaction preserves >40% open space; includes assisted living facilities proposed by buyer.","JLL Capital Markets arranged the sale; deal includes customary conditions and contingencies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191744,"accession_number":"0001437749-24-031299","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-10-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"NY Supreme Court dismisses Article 78 petition against Gyrodyne's Flowerfield subdivision approval","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["On October 11, 2024, the NY Supreme Court ruled in favor of Gyrodyne, dismissing the Article 78 petition challenging the 8-lot subdivision of its Flowerfield property.","Justice Maureen T. Liccione found the petition defective and the Planning Board took the requisite hard look under SEQRA.","Gyrodyne continues seeking final subdivision approval and is conducting a national marketing effort via JLL Capital Markets to sell the property with entitlements.","CEO Gary Fitlin called the decision a major milestone that reaffirms the company's commitment to unlocking Flowerfield's value for shareholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191743,"accession_number":"0001437749-24-031068","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-10-11T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Gyrodyne LLC reports 2024 annual meeting voting results","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Director Ronald J. Macklin elected with 1,030,041 for, 325,673 withheld, and 585,051 broker non-votes.","Say-on-pay approved: 1,061,249 for, 283,493 against, 10,972 abstain (broker non-votes 585,051).","Baker Tilly US, LLP ratified as auditor for 2024: 1,816,419 for, 119,241 against, 5,105 abstain.","Turnout: 88.24% of 2,199,308 outstanding shares represented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191742,"accession_number":"0001437749-24-030773","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-10-07T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Gyrodyne CEO: $4.4M rights offering, NAV per share $16.09, Flowerfield entitlements expected late 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Rights offering oversubscribed 65%, net proceeds $4.4M to defend Article 78 litigation and negotiate from strength.","Proforma NAV per share $16.09 at June 2024, down from $17.45 at Dec 2022, but total NAV increased ~$5M to $35.4M.","Occupancy 82% as of June 2024 (down from 85% Dec 2022); annual burn rate ~$1.3M ex-land development and litigation costs.","Debt of $11.3M fixed at 3.75%-3.85% through 2027/2028, largely unaffected by rate hikes.","CEO hopeful for final Flowerfield entitlements late 2024; JLL marketing both properties; open to sale of company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244926,"accession_number":"0001437749-24-007209","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-03-11T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Gyrodyne closes oversubscribed rights offering, raises $5M gross","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $5M from sale of 625,000 shares at $8 per share; net proceeds ~$4.4M.","Rights offering oversubscribed by ~65% (1,031,640 total shares subscribed vs 625,000 offered).","Basic subscriptions 353,164; over-subscription shares 271,836 allocated pro rata at ~40% of requests.","Net proceeds to fund liquidation process, defend Article 78 proceeding, and pay activist-related legal fees.","Shares issued in uncertificated book-entry form."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244925,"accession_number":"0001437749-24-003600","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-02-09T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Court partially denies motions to dismiss in Article 78 proceeding; answer due in 20 days","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Supreme Court of NY, Suffolk County, issued order on Feb 6, 2024, partially denying and granting motions.","Denied motions as to three individual petitioners and the St. James-Head of the Harbor Coalition.","Granted motions as to 20 other individuals and the Village of Head of the Harbor.","Denied Gyrodyne's motion alleging failure to state a claim; must serve an answer within 20 days.","Gyrodyne says order does not affect strategic timeline or net asset estimate; expects sales by end of 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244924,"accession_number":"0001437749-24-003182","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-02-06T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Gyrodyne launches rights offering to raise up to $5M at $8.00 per share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Rights offering to raise up to $5M via 625K shares at $8.00/share.","Existing holders get one non-transferable right per five shares held; each right buys two shares.","Subscription period ends March 7, 2024; may extend to April 6, 2024.","Proceeds for property entitlements, litigation, capital improvements, working capital.","Registration statement declared effective Feb 2, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244923,"accession_number":"0001437749-24-001800","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-01-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Gyrodyne sets record date Jan 29 for $5M rights offering at $8.00/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Record date for proposed rights offering is Jan 29, 2024 at 5:00 p.m. ET.","Rights offering seeks up to $5M gross proceeds; 625,000 shares at $8.00 each.","Shareholders receive one subscription right per five shares; each right buys two shares.","Net proceeds will fund property entitlements, litigation, improvements, and working capital.","Registration statement filed Dec 29, 2023; offering awaits SEC effectiveness."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244922,"accession_number":"0001437749-24-000422","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2024-01-03T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Gyrodyne secures $1.5M term mortgage loan for working capital","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Principal $1.5M from LLYR Resources, LLC; two-year term, floating rate at 1.5% above Wall Street Prime Rate.","Loan secured by first mortgages on Cortlandt Manor, NY properties (1989 & 1987 Crompond Rd; 206 Buttonwood Ave & vacant land).","Company unconditionally guarantees the loan; net proceeds used for general working capital.","Interest payable monthly; loan may be prepaid in whole or in part without prepayment fee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":262370,"accession_number":"0001437749-23-028280","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2023-10-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Gyrodyne shareholders approve all four proposals at 2023 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Jan H. Loeb and Nader G.M. Salour elected as directors for three-year terms with 705,265 and 732,037 FOR votes, respectively.","Restricted Stock Award Plan ratified with 856,420 FOR votes, 128,576 AGAINST.","Non-binding advisory vote on executive compensation passed with 854,360 FOR, 128,867 AGAINST.","Baker Tilly US, LLP ratified as independent auditor for FY2023 with 1,133,470 FOR, 123,662 AGAINST.","84.86% of eligible shares were present at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":262369,"accession_number":"0001437749-23-028132","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2023-10-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Gyrodyne reports estimated NAV of $20.14/share, updates on entitlement delays and activist costs","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Estimated liquidating value $20.14 per share at Q2 2023, up $4.61 from Dec 2021, driven by $11.1M real estate value increase.","Cortlandt Manor received medical district designation (150K sq ft office, 4K retail) in March 2023; Smithtown final approvals expected late 2023/early 2024.","Article 78 proceeding challenging Smithtown subdivision reassigned to second new judge; motion to dismiss filed June 2022 remains undecided.","Shareholder activist campaign (Star Equity) cumulative cost ~$600K through June 2023; total may reach $1M; D&O insurance coverage being pursued.","Company seeking supplemental funding before year-end; $9.6M debt at fixed rates 3.75-3.85% unaffected by Fed hikes; annual debt service ~$650K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":279570,"accession_number":"0001437749-23-025610","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2023-09-11T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Gyrodyne amends bonus plan; directors waive cash for 91,628 shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Director participants waive bonus plan benefits for 91,628 shares under new Stock Plan, subject to shareholder approval.","Retired director forfeited benefits of $1,137,108 returned to company rather than reallocated.","Employee bonus rate: 4.12% up to $50,985,000 net proceeds, 6.72% above; extra 1% if property sold by June 30, 2024.","Benefits for employees delayed until shareholders receive liquidating distributions; early payment if bonus pool reaches $500,000.","Price floor hurdle removed; director rate if stock plan not approved is 5.30% of net selling price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":279569,"accession_number":"0001437749-23-025423","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2023-09-08T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Gyrodyne settles with Star Equity; adopts stock plan for directors, freezes fees","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gyrodyne will submit a new stock incentive plan to shareholders; $579,328 in director bonus benefits exchanged for shares.","Director compensation fees frozen; new shares non-transferable until liquidating distribution to all shareholders.","Star Equity withdraws two director nominations and shareholder proposal, agrees to vote with board (with exceptions) until 30 days before 2024 nomination window.","Star Equity also agrees to standstill provisions and mutual non-disparagement clause."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":279568,"accession_number":"0001437749-23-024453","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2023-08-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Gyrodyne enters confidentiality pact with Star Equity for possible equity plan adoption and bonus plan amendment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Confidentiality agreement signed August 16, 2023 with Star Equity Fund to facilitate discussions about 2023 annual meeting.","Discussions concern possible adoption of an equity compensation plan and amendment to existing retention bonus plan.","Confidentiality obligations expire on August 25, 2023, or earlier if Gyrodyne publicly discloses board approval of the transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":279567,"accession_number":"0001437749-23-021419","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2023-08-01T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Gyrodyne appoints Jan Loeb to board under cooperation agreement; Palmedo resigns","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Cooperation Agreement with Leap Tide Capital Management; Loeb appointed and will be nominated for 2023 annual meeting.","Director Philip Palmedo resigned effective July 28, 2023 due to health concerns after 27 years on board.","Jan Loeb, managing member of Leap Tide, appointed to fill vacancy; owns 66,000 GYRO shares; receives $42,000 annual director fee.","Annual meeting set for Oct 12, 2023; deadline for shareholder proposals is Aug 11, 2023.","Standstill and voting agreement in effect until after 2024 annual meeting; prohibits public strategic proposals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":318219,"accession_number":"0001437749-23-008352","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2023-03-29T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Gyrodyne's Cortlandt Manor property rezoned as Medical Oriented District; sale planned","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Town Board unanimously adopted SEQRA findings and approved MOD local law on March 20, 2023.","Gyrodyne receives MOD campus designation for 154,000 sq ft (150k medical, 4k retail) on 12.61 acres.","Company intends to sell the property with MOD designation, not develop it.","Law effective upon filing with NY Secretary of State, expected by April 9, 2023.","MOD allows up to 150,000 sq ft medical office, 4,000 sq ft retail, and structured parking."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":318218,"accession_number":"0001437749-23-002016","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2023-01-30T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Gyrodyne CEO letter outlines progress on entitlements, targets dissolution by end of 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Total real estate assets $42.5M, debt $9.8M, loan-to-value 23% as of Q3 2022.","Flowerfield subdivision approval contested via Article 78 proceeding; final approval expected Q3 2023, sale by year-end 2024.","Cortlandt Manor MOD approval expected Q1 2023; occupancy 92% with investment-grade tenants; NewYork-Presbyterian increased to 72%.","Cumulative $147M distributed to shareholders since 1996 (over 1,000% of 1996 market cap of $13M)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":353895,"accession_number":"0001437749-22-021322","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2022-08-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Gyrodyne (GYRO) shareholders withhold majority from both director nominees; say-on-pay fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["85.70% of eligible shares voted at Aug 24 annual meeting; 1,270,616 of 1,482,680 shares represented.","Director nominees Lamb and Smith each received more withhold than for votes (Lamb: 443,666 for, 576,900 withhold; Smith: 446,127 for, 574,529 withhold); 249,960 broker non-votes.","Non-binding advisory say-on-pay failed: 434,230 for, 586,424 against, 2 abstain, plus 249,960 broker non-votes.","Ratification of Baker Tilly as auditor approved: 1,141,119 for, 119,894 against, 9,603 abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.15,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":353894,"accession_number":"0001437749-22-021235","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2022-08-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Gyrodyne NAV per share rises to $15.50; expects Cortlandt entitlements Q4 2022, Smithtown litigation into 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["NAV per share $15.50 as of June 30, 2022, up $0.33 from Dec 31, 2020; real estate value up $3.99M offset by $3.5M higher liquidation costs.","Cortlandt Manor FEIS acceptance expected Q4 2022; subdivision and site plan approval anticipated Q1 2023.","Smithtown preliminary subdivision approved March 2022; Article 78 proceeding filed April 2022; resolution expected by late 2024.","Projected 2022 rental revenue ~$3M (+13% YoY); 59% from NY State, Stony Brook, and NY Presbyterian Hudson Valley.","New $4.95M term loan at adjustable rate (currently 3.75%); Flowerfield loans converted to fixed 3.85%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":371743,"accession_number":"0001437749-22-010115","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2022-04-28T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Gyrodyne faces Article 78 lawsuit seeking to annul Flowerfield subdivision approval","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Petitioners filed Article 78 petition April 26 in NY Supreme Court, Suffolk County, to annul Planning Board's preliminary subdivision approval.","Petition challenges SEQRA findings statement (Sept 2021) and March 30, 2022 preliminary approval of 8-lot subdivision of Flowerfield property.","Gyrodyne says arguments are 'substantially similar' to prior opposition; will vigorously defend Planning Board's determinations.","Preliminary approval subject to conditions: stormwater plan, SEQRA revisions, common area lot separation; final approval expected by end-2024.","No service of petition yet; Article 78 proceeding may take two years or more due to appeals and pandemic court backlog."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":371742,"accession_number":"0001437749-22-007985","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2022-04-01T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Gyrodyne receives unanimous preliminary subdivision approval for Flowerfield property from Smithtown Planning Board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Town of Smithtown Planning Board granted preliminary subdivision approval on March 30, 2022, subject to conditions including stormwater plan and SEQRA findings.","SEQRA findings resolution established thresholds for sanitary discharge, traffic, cleared area, and vegetation for future development.","Next phase requires final approvals from Suffolk County, NY State DOT, and final subdivision map from Smithtown.","Company will continue marketing Flowerfield as nine subdivided lots or consider offers for whole property or the company.","Approval follows over four years of public comment and environmental reviews."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":427676,"accession_number":"0001437749-21-019035","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2021-08-09T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Gyrodyne annual meeting elects two directors; say-on-pay vote shows high abstentions","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Directors Elliot H. Levine and Ronald J. Macklin elected with 460,556 and 458,122 for votes respectively; 420,238 broker non-votes each.","Non-binding advisory vote on executive compensation: 288,273 for, 189,652 against, 294,797 abstain; 420,238 broker non-vote.","Ratification of Baker Tilly US as auditor approved: 883,338 for, 772 against, 308,850 abstain.","Quorum of 1,192,960 shares (84.49% of 1,482,680 eligible) present at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":427675,"accession_number":"0001437749-21-018665","cik":1589061,"company_name":"Gyrodyne, LLC","ticker":"GYRO","form_type":"8-K","filed_at":"2021-08-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Gyrodyne NAV per share falls 28% to $15.22; progress on entitlements but timeline extended to 2022","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["NAV per share $15.22 at March 31, 2021, down 28% from $21.20 a year ago; pandemic blamed for terminated purchase agreements and delays.","Cortlandt Manor: Town now amenable to residential; alternative plan includes 160 units; expected Medical Oriented District adoption early 2022, subdivision approval Q1 2022.","Flowerfield: FEIS accepted March 2021, approved by Suffolk County Planning May 5, 2021; anticipate Findings Statement in 2021, then 12 months to technical approvals and closings.","Rent collection: $2.989M collected out of $3.094M due for April 2020–June 2021 period (96.6%); 60% of 2021 lease revenue from government/healthcare tenants.","Debt facilities: $6M lines converted to permanent loans; new $4.95M term loan expected Q3 2021, raising total debt to ~$10.15M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":15634661.999999998,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}